Techniclone (TCLN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: The Dodgy Ticker who wrote (3699)	7/23/2008 5:27:51 AM
From: Maurice Winn	Read Replies (1) of 3702

Hi Bob. I keep an eye on this discussion and have just noticed the reverse split comment. The point of it was merely to get Techniclone out of the delisting doldrums etc. I haven't checked lately to see if it's still a good idea. I note that thousands of people are dead because Rituxan was not used as a front line treatment for various lymphomas until years after it was commercially available. The time it takes for the medical guilds to figure out something new is extraordinarily long, yet they are dealing with people dying in months, let alone years. Yes, there is a thing called due process, but it's an absurdly lengthy and expensive process. "Safety" for people in terminal disease is different than for regular people. The choice should be their's and not the FDA, doctors etc. Mqurice edit.... yes, it looks like a good idea: finance.yahoo.com 20x or just 10x? 10x = 22 million shares with $1 a share loss means there isn't a lot of market capitalisation left to be used up.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next